This hypothesis is supported by the serum IL-1β and the serum and CSF IL-6 results, which may also explain why an increase in these factors occurred at an early stage in PSP-RS patients examined three to six years after disease initiation. This evidence concerns the gene IL1B and supranuclear palsy, progressive, 1.